Navigation Links
Arno Therapeutics, Inc. Appoints Randy Thurman to the Board of Directors
Date:1/31/2013

FLEMINGTON, N.J., Jan. 31, 2013 /PRNewswire/ -- Arno Therapeutics, Inc. (OTCBB: ARNI), a clinical-stage biopharmaceutical company focused on the development of oncology therapeutics, today announced the appointment of Mr. Randy Thurman to its Board of Directors. With over 30 years of health care industry experience, Mr. Thurman brings a wealth of operational, financial, and business development expertise to Arno.  

"We are extremely pleased to welcome Mr. Thurman to our Board of Directors," said Glenn Mattes , CEO of Arno. "With his extensive knowledge, broad industry network, and history of strong leadership, we are confident that Mr. Thurman will provide Arno with invaluable guidance as we continue the development of our company and its exciting clinical stage assets."

Mr. Thurman became an Operating Partner for AEA Investors LP in October 2012 and previously held the same role with New Mountain Capital LLC since 2008. Mr. Thurman is also Executive Chairman of CogentHMG and was previously Founder, Chairman & CEO of VIASYS Healthcare, Inc., a global leader in respiratory, neurological and medical/surgical technologies. VIASYS Healthcare Inc. was acquired in a transaction which represented a four-fold increase in enterprise value over the five years the company was public. VIASYS was named by Smart Money magazine as one of the "10 Best Investments of the Decade," and Mr. Thurman was named an Ernst & Young Entrepreneur of the Year in 2007. Prior to joining VIASYS Healthcare Inc., Mr. Thurman was CEO of Strategic Reserves, LLC, which provided strategic leadership and M&A advisory services to bio-pharmaceutical, genomic and medical device companies. As Chairman of the Board of Enzon Inc., Mr. Thurman guided the company's growth from a $70 million market capitalization to over $2.5 billion. Previously, he was Chairman & CEO of Corning
'/>"/>

SOURCE Arno Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
2. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
3. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
4. Caliber and ImmunGene Launch Valor Biotherapeutics, a Joint Venture to Develop Antibody-Interferon Fusion Therapeutics to Treat Cancers
5. Cell Therapeutics, Inc. (CTI) Reduces Net Loss for Third Quarter and Nine Months Ended September 30, 2012 Compared to Same Periods in 2011
6. Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
7. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
8. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
9. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
10. Regulus Appoints Mark G. Foletta to its Board of Directors
11. Synteract Appoints Keith Kelson as Chief Financial Officer and Member of Executive Council and Philip Doren, Ph.D., as Vice President, Biometrics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 Capnia, Inc. (NASDAQ: ... medical diagnostics based on its proprietary Sensalyze™ Technology ... announced financial results for the third quarter and ... "Following the completion of our initial public offering ... the recently initiated CoSense® commercial launch," said Anish ...
(Date:12/19/2014)... -- Baptist Health Lexington is the first facility in ... Fibrillation with Electrophysiology Services (EPS) Accreditation status from the Society ... the most common cardiac arrhythmia and has become recognized as ... stroke and possible death. More than 5 million patients in ... and the numbers are rapidly increasing as the population ages. ...
(Date:12/19/2014)... Dec. 18, 2014   Aratana Therapeutics, Inc ... company focused on the licensing, development and commercialization ... positive results from its pivotal field study of ... pain in dogs with osteoarthritis.  In the study, ... scores that were statistically significant compared to placebo ...
Breaking Medicine Technology:Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
(Date:12/21/2014)... (PRWEB) December 21, 2014 Serious Buyer, ... for Vintage 1967 Jm Morrison and the Doors International Ballroom ... This would also be the only time that Morrison's ... was on Nov. 25, 1967. According to Hawley, “This ... They did play the Alexandria Roller Rink earlier that ...
(Date:12/21/2014)... 2014 As testosterone therapy lawsuit ... stroke and blood clots from using testosterone products such ... study shows that the male hormone testosterone may increase ... study published in the Proceedings of the National Academy ... a group of male rats with naturally occurring colon ...
(Date:12/20/2014)... BambooIndustry.com is a leading eco-friendly ... announced its bamboo flooring promotion for the coming ... certified suppliers, and offers the best bamboo products ... current promotion, all customers can enjoy a special ... they know BambooIndustry.com from press releases. , The ...
(Date:12/20/2014)... 2014 DePuy Pinnacle hip lawsuits ... of the artificial hip system was defectively designed ... courts, Bernstein Liebhard LLP reports. According to an ... Court on December 2nd, counsel in 10 DePuy ... plaintiffs on November 19, 2014, with depositions to ...
(Date:12/20/2014)... Angeldress.co.uk, the distinguished wedding dress manufacturer ... dress fans. The company has recently updated its official ... the holiday season, Angeldress Blog has recommended ... , Angeldress.co.uk prides itself in offering a huge selection ... All the company’s outfits are very carefully selected based ...
Breaking Medicine News(10 mins):Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2
... , SUNDAY, Dec. 6 (HealthDay News) -- Early roots of the ... lived thousands or millions of years ago, new research suggests. ... tiger,s genetic material, scientists say, and a remnant of that cat ... may have bitten a monkey, setting off an evolution of the ...
... Dec. 6 Sickle cell disease, a condition characterized by ... most common genetic blood disorders affecting millions of people around ... at the 51st Annual Meeting of the American Society of ... H1N1 pandemic presents for children with this blood disorder, evaluations ...
... ... information and Treatment site www.sleeping-with-a-sleeping-disorder.com is asking people ,who have ... world to donate their best ,insomnia remedies for a good cause. The ... ,Encyclopedia, by YOU, to be sold from the website in early January ...
... phase 1/2 clinical trial that it is a "highly ... multiple myeloma, a cancer of white blood cells in bone ... or better were seen in all of the 66 patients ... 74 percent having a "very good partial response rate" in ...
... , ... The first Football,for Hope Centre in Khayelitsha in the outskirts of ... S. Blatter was joined by,Western Cape Premier Helen Zille, 2010 FIFA ... Football Association,President Kirsten Nematandani and Executive Mayor of the City of ...
... triggers, experts advise , SATURDAY, Dec. 5 (HealthDay News) ... asthma can have bad reactions to certain holiday traditions ... and wheezing, according to the American College of Allergy, ... to live evergreens may choose to decorate with artificial ...
Cached Medicine News:Health News:AIDS May Date Back to Ancient Tiger 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2
Soft red rubber. Adjustable flange. Pediatric sizes available....
Smooth flexible medical grade white low density polyethylene with reinforced block to prevent collapse....
Two-channel, Berman design. Semirigid, nontoxic polyethylene. Individually packaged, 48 per case. Latex Free....
Guedel-style enclosed center channel. Semirigid, nontoxic polyethylene with color-coded bite block. Individually packaged, 48 per case. Latex Free....
Medicine Products: